Galderma Hits Lupin With Rosacea Drug Patent Suit
Dermatology company Galderma Laboratories Inc. and New York University have accused India-based drugmaker Lupin Ltd. of infringing the patents covering Oracea, a treatment for the chronic inflammatory skin disease rosacea....To view the full article, register now.
Already a subscriber? Click here to view full article